Halo Collective Inc
Halo Collective Inc., together with its subsidiaries, engages in the cultivation, manufacture, transportation, and distribution of cannabis and cannabis extracts in Canada and the United States. The company offers concentrates, such as shatter, sauce, live resin, badder, hash, rosin, and THC-A crystals; and oils in both in raw and distillated form in various strains and flavors, as well as strain… Read more
Halo Collective Inc - Asset Resilience Ratio
Halo Collective Inc (HCANF) has an Asset Resilience Ratio of -3.93% as of September 2021. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2013–2020)
This chart shows how Halo Collective Inc's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Halo Collective Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $-6.33 Million | -3.93% |
| Total Liquid Assets | $-6.33 Million | -3.93% |
Asset Resilience Insights
- Limited Liquidity: Halo Collective Inc maintains only -3.93% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Halo Collective Inc Industry Peers by Asset Resilience Ratio
Compare Halo Collective Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF |
Drug Manufacturers - Specialty & Generic | -0.02% |
|
Kamada
NASDAQ:KMDA |
Drug Manufacturers - Specialty & Generic | 21.63% |
|
Dongwha Pharm.Co.Ltd
KO:000020 |
Drug Manufacturers - Specialty & Generic | 1.92% |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078 |
Drug Manufacturers - Specialty & Generic | 0.46% |
|
Yuhan Corp.
KO:000100 |
Drug Manufacturers - Specialty & Generic | 0.99% |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153 |
Drug Manufacturers - Specialty & Generic | 1.81% |
|
Kotra Industries Bhd
KLSE:0002 |
Drug Manufacturers - Specialty & Generic | 9.82% |
|
Yuyu Pharma Inc
KO:000227 |
Drug Manufacturers - Specialty & Generic | 1.74% |
Annual Asset Resilience Ratio for Halo Collective Inc (2013–2020)
The table below shows the annual Asset Resilience Ratio data for Halo Collective Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2020-12-31 | -2.25% | $-1.98 Million | $87.75 Million | -6.09pp |
| 2019-12-31 | 3.83% | $1.61 Million | $41.99 Million | +3.32pp |
| 2018-12-31 | 0.51% | $99.50K | $19.39 Million | -4.11pp |
| 2017-12-31 | 4.62% | $472.35K | $10.23 Million | -93.24pp |
| 2016-12-31 | 97.86% | $1.19 Million | $1.22 Million | 0.00pp |
| 2015-12-31 | 97.86% | $1.19 Million | $1.22 Million | +92.79pp |
| 2014-12-31 | 5.06% | $216.66K | $4.28 Million | -4.08pp |
| 2013-12-31 | 9.15% | $1.02 Million | $11.10 Million | -- |